The global blood gas analyzer market is expected to reach USD 636 million by 2021, at a CAGR of 4.6 percent over the next 5 years. Growth in this market can majorly be attributed to the rising demand for automated and point-of-care electrolyte analyzer devices. Also, the market will be further driven by the growing number of patients being treated in ICUs, NICUs, and emergency departments; the increasing adoption of technologically advanced biosensors and data analysis software is expected to support market growth in the coming years. The commercialization of innovative POC blood gas analyzer based on miniaturized sensors is expected to offer potential growth opportunities to players operating in this market.

North America is expected to dominate the global blood gas analyzer market in 2016. The large share of this regional segment can primarily be attributed to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives. On the other hand, Asia-Pacific market is expected to witness the highest growth during the forecast period, owing to factors such as growing initiatives by market players and increasing patient population base in this region.


 

randox

Digital version